Icahn Offers $5.4 Billion for Mylan, Drug Maker
357838
The billionaire financier Carl Icahn offered to buy the generic drug maker Mylan Laboratories to force the company to drop its acquisition of King Pharmaceuticals.
581364
Here&#39;s another one for the Best Poison Pen Letters of 2004 contest. Mylan Laboratories (nyse: MYL - news - people ) Chairman Milan Puskar says Carl Icahn &quot;miscalculated&quot; with his threats to block Mylan&#39;s merger
386076
In a letter to the board of directors at Mylan Laboratories (nyse: MYL - news - people ), financier Carl Icahn questioned their silence on the recent financial restatements by King Pharmaceuticals (nyse: KG - news - people ), calling the &quot;lack of
189520
Shares of Mylan Laboratories Inc., the largest US maker of generic drugs, surged Thursday after the company said investor Carl Icahn was given the green light by regulators to buy up to $500 million of the company&#39;s stock.
639540
PITTSBURGH Carl Icahn, the largest shareholder of Mylan Laboratories, is now threatening to push for new company directors to stop the generic drug maker&#39;s four (B) billion-dollar takeover bid of King Pharmaceuticals.
550625
Financier Carl Icahn on Friday  offered to buy the shares of generic drugmaker Mylan  Laboratories MYL.N that he does not already own for $4.9  billion, or $20 a share, according to a government filing.
282450
Mylan Laboratories Inc., the biggest US maker of generic drugs, received a $20-a-share bid from Carl Icahn, the company&#39;s largest investor and a critic of Mylan&#39;s plan to buy King Pharmaceuticals Inc.
609796
Despite concerns raised by an investor, Mylan Laboratories Inc. reaffirmed that its proposed acquisition of generic drug maker King Pharmaceuticals Inc.
582905
The head of Mylan Laboratories Inc. lashed out at Wall Street financier Carl Icahn for trying to stop the company&#39;s acquisition of brand-name drug maker King Pharmaceuticals
689474
Billionaire Carl Icahn charged ahead on Monday in his efforts to acquire Reckson Associates Realty Corp.  and an affiliate company for $49 per share, or $4.3 billion in cash and stock, even as his former partners in the deal pulled out of the running.
191627
Check--or checkmate? Carl Icahn, attempting to block Mylan Laboratories (nyse: MYL - news - people ) in its buyup of King Pharmaceuticals (nyse: KG - news - people ), made his move: Earlier this month, the
599973
Investor Carl Icahn issued a $20-per-share bid to acquire Mylan Laboratories Inc. on Friday and said &quot;at least&quot; three other potential buyers in the generic drug industry could offer more.
102229
The Pittsburgh-based drug maker Mylan shares shot up 10 percent after Carl Ichan offered $5.38 billion for the company&#39;s shares he doesn&#39;t already own.
174444
U.S. auto parts maker Lear Corp.   said on Friday that it has accepted top shareholder and  billionaire investor Carl Icahn's $2.31 billion cash buyout  offer and may solicit alternate proposals for 45 days.
165524
Mylan Laboratories Inc. was one of the few drug makers whose stock closed up Friday with the sector down for a second day as fresh squabbles between veteran financier Carl Icahn and the company&#39;s board erupted.
97449
Investor Carl Icahn on Thursday detailed his objections to Mylan Laboratories Inc.&#39;s proposed $4 billion acquisition of King Pharmaceuticals Inc.
508157
A group led by the investor Carl C. Icahn has agreed to increase its bid for the Lear Corporation, the automotive supplier, by about 3.5 percent, to roughly $2.9 billion.